Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol.
Saved in:
| Title: | Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol. |
|---|---|
| Authors: | Svensson, Jonas E.1,2 (AUTHOR), Bolin, Martin1 (AUTHOR), Thor, Daniel3,4 (AUTHOR), Williams, Pete A.5 (AUTHOR), Brautaset, Rune5 (AUTHOR), Carlsson, Marcus6 (AUTHOR), Sörensson, Peder7 (AUTHOR), Marlevi, David6,8 (AUTHOR), Spin-Neto, Rubens9 (AUTHOR), Probst, Monika10 (AUTHOR), Hagman, Göran2,11 (AUTHOR), Morén, Anton Forsberg1 (AUTHOR), Kivipelto, Miia2,11,12,13 (AUTHOR), Plavén-Sigray, Pontus1,14 (AUTHOR) pontus.plaven-sigray@ki.se |
| Source: | BMC Neurology. 4/4/2024, Vol. 24 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712377 |
|---|---|
| DOI: | 10.1186/s12883-024-03596-1 |